METODOS PARA PREVENIR Y TRATAR TRASTORNOS METABOLICOS Y NUEVOS DERIVADOS DE PIRAZOL-O-GLUCOSIDO
Métodos para : prevenir/tratar trastornos metabólicos, mejorar el control glucémico, prevenir la progresión desde la tolerancia alterada a la glucosa, la resitencia a la insulina y/o desde el síndrome metabólico hasta la diabetes mellitus de tipo 2, prevenir/tratar las complicaciones de la diabetes...
Gespeichert in:
Hauptverfasser: | , , , , , , , , , , , , , |
---|---|
Format: | Patent |
Sprache: | spa |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | PETER EICKELMANN KOICHI FUJITA KATSUMI MAEZONO LEO THOMAS KOJI OHSUMI SABINE QUISPE BRAVO ROLAND MAIER FRANK HIMMELSBACH KLAUS DUGI NOZOMU ISHIDA REGINE RITTER TOSHIHIRO HATANAKA RUDIGER STREICHER EDWARD LEON BARSOUMIAN |
description | Métodos para : prevenir/tratar trastornos metabólicos, mejorar el control glucémico, prevenir la progresión desde la tolerancia alterada a la glucosa, la resitencia a la insulina y/o desde el síndrome metabólico hasta la diabetes mellitus de tipo 2, prevenir/tratar las complicaciones de la diabetes mellitus, reducir el peso, prevenir/tratar la degeneración de las células beta pancreáticas, tratar hiperinsulinemia y resistencia a la insulina y diabetes de tipo 1, en pacientes que lo necesiten, mediante administración de composición farmacéutica que comprende pirazol-O-glucósido como se define en la reivindicación 1, o su profármaco, o su sal farmacéuticamente aceptable.
The invention relates to methods for preventing or treating metabolic disorders, for improving glycemic control, for preventing progression from impaired glucose tolerance, insulin resistance and/or from metabolic syndrome to type 2 diabetes mellitus, for preventing or treating of complications of diabetes mellitus, for reducing the weight, for preventing or treating the degeneration of pancreatic beta cells, for treating hyperinsulinemia and insulin resistance and diabetes type 1, in patients in need thereof by administering a pharmaceutical composition comprising a pyrazole-O-glycoside as defined in claim 1, or a prodrug thereof, or a pharmaceutically acceptable salt thereof. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_UY29694A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>UY29694A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_UY29694A13</originalsourceid><addsrcrecordid>eNrjZIj3dQ3xd_EPVghwDHJUCAhyDXP18wxSiFQICXIMcQwCUcEh_kF-QBVAlY5O_j6ezkB2pIJfqGsYkOHiGuQZ5ugCZikEeAY5Rvn76PrruvuEApV5uvjzMLCmJeYUp_JCaW4GOTfXEGcP3dSC_PjU4oLE5NS81JL40EgjSzNLE0dDY4IKAGydMrA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>METODOS PARA PREVENIR Y TRATAR TRASTORNOS METABOLICOS Y NUEVOS DERIVADOS DE PIRAZOL-O-GLUCOSIDO</title><source>esp@cenet</source><creator>PETER EICKELMANN ; KOICHI FUJITA ; KATSUMI MAEZONO ; LEO THOMAS ; KOJI OHSUMI ; SABINE QUISPE BRAVO ; ROLAND MAIER ; FRANK HIMMELSBACH ; KLAUS DUGI ; NOZOMU ISHIDA ; REGINE RITTER ; TOSHIHIRO HATANAKA ; RUDIGER STREICHER ; EDWARD LEON BARSOUMIAN</creator><creatorcontrib>PETER EICKELMANN ; KOICHI FUJITA ; KATSUMI MAEZONO ; LEO THOMAS ; KOJI OHSUMI ; SABINE QUISPE BRAVO ; ROLAND MAIER ; FRANK HIMMELSBACH ; KLAUS DUGI ; NOZOMU ISHIDA ; REGINE RITTER ; TOSHIHIRO HATANAKA ; RUDIGER STREICHER ; EDWARD LEON BARSOUMIAN</creatorcontrib><description>Métodos para : prevenir/tratar trastornos metabólicos, mejorar el control glucémico, prevenir la progresión desde la tolerancia alterada a la glucosa, la resitencia a la insulina y/o desde el síndrome metabólico hasta la diabetes mellitus de tipo 2, prevenir/tratar las complicaciones de la diabetes mellitus, reducir el peso, prevenir/tratar la degeneración de las células beta pancreáticas, tratar hiperinsulinemia y resistencia a la insulina y diabetes de tipo 1, en pacientes que lo necesiten, mediante administración de composición farmacéutica que comprende pirazol-O-glucósido como se define en la reivindicación 1, o su profármaco, o su sal farmacéuticamente aceptable.
The invention relates to methods for preventing or treating metabolic disorders, for improving glycemic control, for preventing progression from impaired glucose tolerance, insulin resistance and/or from metabolic syndrome to type 2 diabetes mellitus, for preventing or treating of complications of diabetes mellitus, for reducing the weight, for preventing or treating the degeneration of pancreatic beta cells, for treating hyperinsulinemia and insulin resistance and diabetes type 1, in patients in need thereof by administering a pharmaceutical composition comprising a pyrazole-O-glycoside as defined in claim 1, or a prodrug thereof, or a pharmaceutically acceptable salt thereof.</description><language>spa</language><subject>CHEMISTRY ; DERIVATIVES THEREOF ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; NUCLEIC ACIDS ; NUCLEOSIDES ; NUCLEOTIDES ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS ; SUGARS</subject><creationdate>2007</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20070228&DB=EPODOC&CC=UY&NR=29694A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25563,76318</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20070228&DB=EPODOC&CC=UY&NR=29694A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>PETER EICKELMANN</creatorcontrib><creatorcontrib>KOICHI FUJITA</creatorcontrib><creatorcontrib>KATSUMI MAEZONO</creatorcontrib><creatorcontrib>LEO THOMAS</creatorcontrib><creatorcontrib>KOJI OHSUMI</creatorcontrib><creatorcontrib>SABINE QUISPE BRAVO</creatorcontrib><creatorcontrib>ROLAND MAIER</creatorcontrib><creatorcontrib>FRANK HIMMELSBACH</creatorcontrib><creatorcontrib>KLAUS DUGI</creatorcontrib><creatorcontrib>NOZOMU ISHIDA</creatorcontrib><creatorcontrib>REGINE RITTER</creatorcontrib><creatorcontrib>TOSHIHIRO HATANAKA</creatorcontrib><creatorcontrib>RUDIGER STREICHER</creatorcontrib><creatorcontrib>EDWARD LEON BARSOUMIAN</creatorcontrib><title>METODOS PARA PREVENIR Y TRATAR TRASTORNOS METABOLICOS Y NUEVOS DERIVADOS DE PIRAZOL-O-GLUCOSIDO</title><description>Métodos para : prevenir/tratar trastornos metabólicos, mejorar el control glucémico, prevenir la progresión desde la tolerancia alterada a la glucosa, la resitencia a la insulina y/o desde el síndrome metabólico hasta la diabetes mellitus de tipo 2, prevenir/tratar las complicaciones de la diabetes mellitus, reducir el peso, prevenir/tratar la degeneración de las células beta pancreáticas, tratar hiperinsulinemia y resistencia a la insulina y diabetes de tipo 1, en pacientes que lo necesiten, mediante administración de composición farmacéutica que comprende pirazol-O-glucósido como se define en la reivindicación 1, o su profármaco, o su sal farmacéuticamente aceptable.
The invention relates to methods for preventing or treating metabolic disorders, for improving glycemic control, for preventing progression from impaired glucose tolerance, insulin resistance and/or from metabolic syndrome to type 2 diabetes mellitus, for preventing or treating of complications of diabetes mellitus, for reducing the weight, for preventing or treating the degeneration of pancreatic beta cells, for treating hyperinsulinemia and insulin resistance and diabetes type 1, in patients in need thereof by administering a pharmaceutical composition comprising a pyrazole-O-glycoside as defined in claim 1, or a prodrug thereof, or a pharmaceutically acceptable salt thereof.</description><subject>CHEMISTRY</subject><subject>DERIVATIVES THEREOF</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>NUCLEIC ACIDS</subject><subject>NUCLEOSIDES</subject><subject>NUCLEOTIDES</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><subject>SUGARS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2007</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZIj3dQ3xd_EPVghwDHJUCAhyDXP18wxSiFQICXIMcQwCUcEh_kF-QBVAlY5O_j6ezkB2pIJfqGsYkOHiGuQZ5ugCZikEeAY5Rvn76PrruvuEApV5uvjzMLCmJeYUp_JCaW4GOTfXEGcP3dSC_PjU4oLE5NS81JL40EgjSzNLE0dDY4IKAGydMrA</recordid><startdate>20070228</startdate><enddate>20070228</enddate><creator>PETER EICKELMANN</creator><creator>KOICHI FUJITA</creator><creator>KATSUMI MAEZONO</creator><creator>LEO THOMAS</creator><creator>KOJI OHSUMI</creator><creator>SABINE QUISPE BRAVO</creator><creator>ROLAND MAIER</creator><creator>FRANK HIMMELSBACH</creator><creator>KLAUS DUGI</creator><creator>NOZOMU ISHIDA</creator><creator>REGINE RITTER</creator><creator>TOSHIHIRO HATANAKA</creator><creator>RUDIGER STREICHER</creator><creator>EDWARD LEON BARSOUMIAN</creator><scope>EVB</scope></search><sort><creationdate>20070228</creationdate><title>METODOS PARA PREVENIR Y TRATAR TRASTORNOS METABOLICOS Y NUEVOS DERIVADOS DE PIRAZOL-O-GLUCOSIDO</title><author>PETER EICKELMANN ; KOICHI FUJITA ; KATSUMI MAEZONO ; LEO THOMAS ; KOJI OHSUMI ; SABINE QUISPE BRAVO ; ROLAND MAIER ; FRANK HIMMELSBACH ; KLAUS DUGI ; NOZOMU ISHIDA ; REGINE RITTER ; TOSHIHIRO HATANAKA ; RUDIGER STREICHER ; EDWARD LEON BARSOUMIAN</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_UY29694A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>spa</language><creationdate>2007</creationdate><topic>CHEMISTRY</topic><topic>DERIVATIVES THEREOF</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>NUCLEIC ACIDS</topic><topic>NUCLEOSIDES</topic><topic>NUCLEOTIDES</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><topic>SUGARS</topic><toplevel>online_resources</toplevel><creatorcontrib>PETER EICKELMANN</creatorcontrib><creatorcontrib>KOICHI FUJITA</creatorcontrib><creatorcontrib>KATSUMI MAEZONO</creatorcontrib><creatorcontrib>LEO THOMAS</creatorcontrib><creatorcontrib>KOJI OHSUMI</creatorcontrib><creatorcontrib>SABINE QUISPE BRAVO</creatorcontrib><creatorcontrib>ROLAND MAIER</creatorcontrib><creatorcontrib>FRANK HIMMELSBACH</creatorcontrib><creatorcontrib>KLAUS DUGI</creatorcontrib><creatorcontrib>NOZOMU ISHIDA</creatorcontrib><creatorcontrib>REGINE RITTER</creatorcontrib><creatorcontrib>TOSHIHIRO HATANAKA</creatorcontrib><creatorcontrib>RUDIGER STREICHER</creatorcontrib><creatorcontrib>EDWARD LEON BARSOUMIAN</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>PETER EICKELMANN</au><au>KOICHI FUJITA</au><au>KATSUMI MAEZONO</au><au>LEO THOMAS</au><au>KOJI OHSUMI</au><au>SABINE QUISPE BRAVO</au><au>ROLAND MAIER</au><au>FRANK HIMMELSBACH</au><au>KLAUS DUGI</au><au>NOZOMU ISHIDA</au><au>REGINE RITTER</au><au>TOSHIHIRO HATANAKA</au><au>RUDIGER STREICHER</au><au>EDWARD LEON BARSOUMIAN</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>METODOS PARA PREVENIR Y TRATAR TRASTORNOS METABOLICOS Y NUEVOS DERIVADOS DE PIRAZOL-O-GLUCOSIDO</title><date>2007-02-28</date><risdate>2007</risdate><abstract>Métodos para : prevenir/tratar trastornos metabólicos, mejorar el control glucémico, prevenir la progresión desde la tolerancia alterada a la glucosa, la resitencia a la insulina y/o desde el síndrome metabólico hasta la diabetes mellitus de tipo 2, prevenir/tratar las complicaciones de la diabetes mellitus, reducir el peso, prevenir/tratar la degeneración de las células beta pancreáticas, tratar hiperinsulinemia y resistencia a la insulina y diabetes de tipo 1, en pacientes que lo necesiten, mediante administración de composición farmacéutica que comprende pirazol-O-glucósido como se define en la reivindicación 1, o su profármaco, o su sal farmacéuticamente aceptable.
The invention relates to methods for preventing or treating metabolic disorders, for improving glycemic control, for preventing progression from impaired glucose tolerance, insulin resistance and/or from metabolic syndrome to type 2 diabetes mellitus, for preventing or treating of complications of diabetes mellitus, for reducing the weight, for preventing or treating the degeneration of pancreatic beta cells, for treating hyperinsulinemia and insulin resistance and diabetes type 1, in patients in need thereof by administering a pharmaceutical composition comprising a pyrazole-O-glycoside as defined in claim 1, or a prodrug thereof, or a pharmaceutically acceptable salt thereof.</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | spa |
recordid | cdi_epo_espacenet_UY29694A1 |
source | esp@cenet |
subjects | CHEMISTRY DERIVATIVES THEREOF HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY NUCLEIC ACIDS NUCLEOSIDES NUCLEOTIDES ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SUGARS |
title | METODOS PARA PREVENIR Y TRATAR TRASTORNOS METABOLICOS Y NUEVOS DERIVADOS DE PIRAZOL-O-GLUCOSIDO |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-10T11%3A30%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=PETER%20EICKELMANN&rft.date=2007-02-28&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUY29694A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |